High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma.
- 1 September 1993
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 11 (9) , 1832
- https://doi.org/10.1200/jco.1993.11.9.1832
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: